Compugen (CGEN) Total Current Liabilities (2009 - 2026)
Compugen (CGEN) posted quarterly Total Current Liabilities of $22.0 million for Q1 2026, up 4.97% year-over-year from $21.0 million in Q1 2025, and down 2.36% on a QoQ basis from $22.6 million in Q4 2025.
Compugen (CGEN) Total Current Liabilities (2009 - 2026) Analysis & Trends
Compugen has reported Total Current Liabilities for 18 years, with the latest figure at $22.0 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $22.0 million, up 4.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.0 million (up 4.97% YoY), and the FY2025 annual result was $22.6 million, up 11.95% from the prior year.
- Total Current Liabilities eased to $22.0 million in Q1 2026, from $22.6 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $27.8 million in Q3 2024 and troughed at $10.4 million in Q3 2023.
- A 5-year average of $18.7 million and a median of $20.3 million in 2025 frame the typical range for Total Current Liabilities.
- The widest annual swing landed in 2023, when Total Current Liabilities sank 31.74%; it then soared 167.55% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $11.9 million in 2022, then surged by 120.37% to $26.3 million in 2023, then dropped by 23.25% to $20.2 million in 2024, then grew by 11.95% to $22.6 million in 2025, then declined by 2.36% to $22.0 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $22.0 million in Q1 2026, $22.6 million in Q4 2025, and $20.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 22.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.04 Mn |
| Dec 31, 2025 | 22.57 Mn |
| Sep 30, 2025 | 20.28 Mn |
| Jun 30, 2025 | 20.58 Mn |
| Mar 31, 2025 | 20.99 Mn |
| Dec 31, 2024 | 20.16 Mn |
| Sep 30, 2024 | 27.76 Mn |
| Jun 30, 2024 | 24.77 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 26.27 Mn |
| Sep 30, 2023 | 10.38 Mn |
| Jun 30, 2023 | 10.80 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 11.92 Mn |
| Sep 30, 2022 | 14.77 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 15.70 Mn |
| Dec 31, 2021 | 17.10 Mn |
| Sep 30, 2021 | 15.26 Mn |
| Jun 30, 2021 | 11.85 Mn |